Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of <scp>ALETHEIA</scp>, a multi‐country observational study

An increased understanding of patterns of ticagrelor 60 mg use and associated clinical outcomes among high-risk patients with a prior MI is needed. The a priori specified stepwise approach adapted in this observational study is expected to generate useful evidence for clinical decision-making and treatment optimization.